Not all patients with CLL have to have therapy. Irrespective of all the latest innovations, the iwCLL however suggests watchful observation for individuals with asymptomatic disease.86 This advice is predicated on at the very least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and